Faculty Profiles - YONEYAMA Tohru

Papers - YONEYAMA Tohru

Division display >> ／ All the affair displays1 - 326 of about 326

Annexin A1-Targeted d-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate Cancer.

Ozaki K, Yoneyama T, Kubota Y, Yoneyama MS, Nonaka M, Suzuki T, Tanaka R, Ohyama C, Hatakeyama S

The Prostate 2025.7

Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population.

Yuki Miura, Tohru Yoneyama, Hayato Yamamoto, Hiromu Suzuki, Takuma Otsubo, Eriko Fujita, Fumiyasu Tsushima, Shintaro Goto, Teppei Okamoto, Naoki Fujita, Masahiro Ishiyama, Tadashi Yoshizawa, Shingo Kakeda, Shingo Hatakeyama, Chikara Ohyama

The Prostate 85 ( 9 ) 869 - 887 2025.3

PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Daichi Sasaki, Tohru Yoneyama, Fumiya Yoneyama, Kai Ozaki, Yusuke Ozaki, Yuki Miura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Shintaro Goto, Tadashi Yoshizawa, Akira Kurose, Hiroshi Kijima, Chikara Ohyama, Shingo Hatakeyama

International journal of urology : official journal of the Japanese Urological Association 2025.5

The Effects of the Blood-Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies.

Hikari Miura, Tomoko Hamaya, Tohru Yoneyama, Tadashi Shimoyama, Fumiyasu Tsushima, Kyo Togashi, Yuki Miura, Anna Yoneyama, Hiroyuki Sato, Sosuke Omizo, Kazuyuki Mori, Hirotake Kodama, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Shingo Kakeda, Chikara Ohyama, Shingo Hatakeyama

The Prostate 85 ( 11 ) 1062 - 1068 2025.5

Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.

Ozaki K, Yamamoto H, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S

International journal of urology : official journal of the Japanese Urological Association 32 ( 6 ) 679 - 685 2025.3

特集今のうちにしっかり理解　最新の前立腺癌診療と近未来予想図〈診断〉 PSAを超えるバイオマーカーS2,3PSA%検査の実力

米山徹

臨床泌尿器科 79 ( 1 ) 6 - 14 2025.1

PhiとSi,3PSA%の監視療法におけるプロトコール生検の再分類予測の検討 PRIAS-JAPAN

加藤琢磨, 米山徹, 畠山真悟, 佐藤琢磨, 松本隆児, 森啓一郎, 谷川俊貴, 坂本信一, 井上雅晴, 土肥洋一郎, 福原浩, 納谷幸男, 大山力, 杉元幹史

日本癌治療学会学術集会抄録集 62回 O21 - 6 2024.10

α2,3シアル化PSAとα1,6フコシル化PSAを組み合わせたSF indexによる前立腺癌診断

波多野浩士, 米山徹, 畠山真吾, 冨山栄輔, 土屋睦美, 西本光寿, 吉村一宏, 三善英知, 植村天受, 大山力, 野々村祝夫, 藤田和利

泌尿器外科 37 ( 8 ) 919 - 920 2024.8

TOPICS 泌尿器科学前立腺癌の新規体外診断薬S2,3PSA%

大山力, 米山徹, 畠山真吾

医学のあゆみ 290 ( 2 ) 182 - 183 2024.7

トピックス新規前立腺癌診断マーカー S2,3PSA%の有用性

畠山真吾, 米山徹, 大山力

検査と技術 52 ( 6 ) 568 - 570 2024.6

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.

Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Kazuyuki Mori, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Scientific reports 13 ( 1 ) 15098 - 15098 2023.9

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.

Okuyama Y, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka T, Fujita N, Okamoto T, Mori K, Yamamoto H, Yoneyama T, Hashimoto Y, Matsuoka T, Sato S, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 30 ( 8 ) 649 - 657 2023.5

Summary of the clinical practice manual for late-onset hypogonadism.

Ide H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S

International journal of urology : official journal of the Japanese Urological Association 30 ( 5 ) 422 - 430 2023.5

Relationship between lower urinary tract symptoms and frailty.

Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 30 ( 7 ) 606 - 613 2023.4

Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.

Numakura K, Miyake M, Kobayashi M, Muto Y, Sekine Y, Nishimura N, Iida K, Shiga M, Morizane S, Yoneyama T, Matsumura Y, Abe T, Yamada T, Matsumoto K, Inokuchi J, Nishiyama N, Taoka R, Kobayashi T, Kojima T, Kitamura H, Nishiyama H, Fujimoto K, Habuchi T

Cancers 15 ( 7 ) 2023.3

Trends in the age of hospitalized patients with urological cancers: A 17-year experience.

Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 30 ( 7 ) 572 - 578 2023.3

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

Scientific reports 13 ( 1 ) 3436 2023.3

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology 12 ( 2 ) 161 - 167 2023.2

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.

Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C

Cancers 15 ( 5 ) 2023.2

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

The Prostate 83 ( 2 ) 198 - 203 2023.2

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

PloS one 18 ( 2 ) e0275921 2023.2

腎結石形成に関与する糖鎖変異オステオポンチンの探索

阿南剛, 米山徹, 廣瀬卓男, 畠山真吾, 森建文, 大山力, 佐藤信

日本尿路結石症学会誌 21 ( 2 ) 64 - 65 2023.2

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study.

Naoki Fujita, Masaki Momota, Yusuke Ozaki, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The world journal of men's health 41 ( 4 ) 900 - 908 2023.1

Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.

Fujita N, Ishida M, Iwane T, Suganuma H, Matsumoto M, Hatakeyama S, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C

The world journal of men's health 41 ( 3 ) 701 - 711 2023.1

Aberrant glycosylation of osteopontin in a rat renal stone formation model: A preliminary study.

Go Anan, Tohru Yoneyama, Takuo Hirose, Makoto Sato, Takefumi Mori, Chikara Ohyama

BJUI compass 4 ( 1 ) 63 - 65 2023.1

イムノグロブリン<i>N</i>型糖鎖プロファイルを基盤とした機械学習アプローチによる腎移植後の拒絶予測モデルの開発

小玉寛健, 米山徹, 岩村大径, 藤田尚紀, 田中壽和, 畠山真吾, 柿崎育子, 大山力

移植 58 ( Supplement ) s226_2 - s226_2 2023

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Cancers 14 ( 24 ) 2022.12

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C

World journal of urology 41 ( 1 ) 67 - 75 2022.12

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 41 ( 5 ) 254.e17 - 254.e24 2022.12

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 1 - 7 2022.12

Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis.

Fujita N, Momota M, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 193 - 201 2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Tomoko Hamaya, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Andrology 10 ( 8 ) 1548 - 1555 2022.11

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Noritaka Ishii, Shingo Hatakeyama, Tohru Yoneyama, Ryuma Tanaka, Takuma Narita, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022.10

Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy.

Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1235 - 1237 2022.10

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Scientific reports 12 ( 1 ) 13786 - 13786 2022.8

Selective reaction monitoring approach using structure-defined synthetic glycopeptides for validating glycopeptide biomarkers pre-determined by bottom-up glycoproteomics.

Kouta Shiratori, Yasuhiro Yokoi, Hajime Wakui, Nozomi Hirane, Michiru Otaki, Hiroshi Hinou, Tohru Yoneyama, Shingo Hatakeyama, Satoshi Kimura, Chikara Ohyama, Shin-Ichiro Nishimura

RSC advances 12 ( 33 ) 21385 - 21393 2022.7

Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study.

Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 772 - 773 2022.7

Kidney Transplantation in a Patient With Noonan Syndrome: A Case Report.

Kodama H, Hatakeyama S, Hamaya T, Murakami R, Murasawa H, Yamamoto H, Yoneyama T, Ohyama C

Transplantation proceedings 54 ( 6 ) 1601 - 1603 2022.7

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.

Hiromichi Iwamura, Shingo Hatakeyama, Takuma Narita, Yusuke Ozaki, Sakae Konishi, Hirotaka Horiguchi, Hirotake Kodama, Yuta Kojima, Naoki Fujita, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Scientific reports 12 ( 1 ) 9675 - 9675 2022.6

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The world journal of men's health 41 ( 2 ) 373 - 381 2022.5

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022.5

Machine learning diagnosis by immunoglobulin N-glycan signature for precision diagnosis of urological diseases.

Hiromichi Iwamura, Kei Mizuno, Shusuke Akamatsu, Shingo Hatakeyama, Yuki Tobisawa, Shintaro Narita, Takuma Narita, Shinichi Yamashita, Sadafumi Kawamura, Toshihiko Sakurai, Naoki Fujita, Hirotake Kodama, Daisuke Noro, Ikuko Kakizaki, Shigeyuki Nakaji, Ken Itoh, Norihiko Tsuchiya, Akihiro Ito, Tomonori Habuchi, Chikara Ohyama, Tohru Yoneyama

Cancer science 113 ( 7 ) 2434 - 2445 2022.5

Renal metastasis of ovarian granulosa cell tumor.

Kyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masayuki Futagami, Chikara Ohyama

IJU case reports 5 ( 3 ) 186 - 190 2022.5

Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 5 ) 476 - 478 2022.5

TMEM2 expression is downregulated as bladder cancer invades the muscle layer.

Mihoko Sutoh Yoneyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tadashi Suzuki, Chikara Ohyama

Biochemical and biophysical research communications 613 1 - 6 2022.4

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.

Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Scientific reports 12 ( 1 ) 5876 - 5876 2022.4

Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022.3

Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.

Konishi S, Hatakeyama S, Imai A, Okita K, Kido K, Ozaki Y, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 162 - 168 2022.3

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Miura Y, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Okuyama Y, Kojima Y, Noro D, Tokui N, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 146 - 153 2022.3

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.

Ozaki K, Hatakeyama S, Tanaka T, Noro D, Tokui N, Horiguchi H, Okuyama Y, Fujita N, Okamoto T, Okamoto A, Suzuki Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 139 - 145 2022.3

Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.

Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K

International journal of urology : official journal of the Japanese Urological Association 29 ( 3 ) 242 - 249 2022.3

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

BJUI compass 3 ( 2 ) 154 - 161 2022.3

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C

Urologic oncology 40 ( 2 ) 64.e1 - 64.e8 2022.2

フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である

小玉寛健, 畠山真吾, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 109回 PP33 - 04 2021.12

イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉寛健, 米山徹, 田中壽和, 野呂大輔, 飛澤悠葵, 山本勇人, 須藤晋一郎, 畠山真吾, 米山高弘, 橋本安弘, 柿崎育子, 中路重之, 大山力

日本泌尿器科学会総会 109回 AOP07 - 01 2021.12

Simultaneous analysis of serum a 2,3-linked sialylation and core-type fucosylation of PSA for the detection of clinically significant prostate cancer(和訳中)

波多野浩士, 米山徹, 畠山真吾, 藤田和利, 三善英知, 吉村一宏, 植村天受, 大山力, 野々村祝夫

日本泌尿器科学会総会 109回 ISP02 - 03 2021.12

Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.

Koji Hatano, Tohru Yoneyama, Shingo Hatakeyama, Eisuke Tomiyama, Mutsumi Tsuchiya, Mitsuhisa Nishimoto, Kazuhiro Yoshimura, Eiji Miyoshi, Hirotsugu Uemura, Chikara Ohyama, Norio Nonomura, Kazutoshi Fujita

British journal of cancer 126 ( 5 ) 764 - 770 2021.11

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.

Sakae Konishi, Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Daisuke Noro, Tendo Sato, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Scientific reports 11 ( 1 ) 22103 - 22103 2021.11

血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉寛健, 米山徹, 田中壽和, 野呂大輔, 須藤晋一郎, 飛澤悠葵, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 柿崎育子, 中路重之, 大山力

日本癌治療学会学術集会抄録集 59回 O18 - 3 2021.10

高リスク上部尿路上皮癌への術前化学療法と腫瘍学的転帰の傾向多施設後ろ向き研究

濱谷智子, 畠山真吾, 田中壽和, 久保田優花, 富樫赳, 細越正吾, 藤田尚紀, 日下歩, 得居範子, 岡本哲平, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会抄録集 59回 O22 - 1 2021.10

Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Takuma Narita, Hirotake Kodama, Masaki Momota, Hiroyuki Ito, Shintaro Narita, Fumiyasu Tsushima, Koji Mitsuzuka, Takahiro Yoneyama, Yasuhiro Hashimoto, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Shingo Kakeda, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama

The Prostate 81 ( 16 ) 1411 - 1427 2021.9

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Takuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Mitsuru Saito, Shintaro Narita, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南剛, 米山徹, 畠山真吾, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本腎臓学会誌 63 ( 4 ) 447 - 447 2021.6

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, Yuichiro Suzuki, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Naoki Fujita, Sakae Konishi, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 12 ) 832.e17 - 832.e23 2021.4

Narrative review of urinary glycan biomarkers in prostate cancer.

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Chikara Ohyama

Translational andrology and urology 10 ( 4 ) 1850 - 1864 2021.4

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology 39 ( 4 ) 238.e9-238.e17 - 238.e17 2021.4

Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.

Miyake M, Iida K, Nishimura N, Miyamoto T, Fujimoto K, Tomida R, Matsumoto K, Numakura K, Inokuchi J, Morizane S, Yoneyama T, Matsumura Y, Abe T, Inoue M, Yamada T, Terada N, Hirao S, Uemura M, Matsushita Y, Taoka R, Kobayashi T, Kojima T, Matsui Y, Kitamura H, Nishiyama H, Japanese Urological Oncology Group

BMC cancer 21 ( 1 ) 266 2021.3

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

World journal of urology 39 ( 9 ) 3265 - 3271 2021.3

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 3 ) 191.e1-191.e8 - 191.e8 2021.3

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 3 ) 192.e7-192.e14 - 192.e14 2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Hiromichi Iwamura, Shingo Hatakeyama, Masaki Momota, Yuta Kojima, Takuma Narita, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Kyou Togashi, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 3 ) 194.e9-194.e16 - 194.e16 2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 3 ) 191.e9-191.e16 - 191.e16 2021.3

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.

Masayuki Tomioka, Tohru Yoneyama, Yuki Tobisawa, Kota Kawase, Chie Nakai, Manabu Takai, Daiki Kato, Koji Iinuma, Keita Nakane, Kosuke Mizutani, Yasuhiro Hashimoto, Takuya Koie

Translational andrology and urology 10 ( 3 ) 1192 - 1201 2021.3

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU international 128 ( 4 ) 468 - 476 2021.2

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki

International urology and nephrology 53 ( 2 ) 275 - 280 2021.2

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer medicine 10 ( 4 ) 1297 - 1313 2021.2

Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N Fukuda, Chikara Ohyama

BMC cancer 21 ( 1 ) 105 - 105 2021.1

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicenter retrospective study.

BJU international 2021.1

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Cancer medicine 2021.1

Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

BMC cancer 21 ( 1 ) 72 - 72 2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 1 ) 75.e9-75.e16 - 75.e16 2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Kido K, Hatakeyama S, Numakura K, Tanaka T, Oikawa M, Noro D, Hosogoe S, Narita S, Inoue T, Yoneyama T, Ito H, Nishimura S, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of clinical oncology 26 ( 1 ) 154 - 162 2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis 105 ( 3-4 ) 232 - 239 2021

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本内分泌学会雑誌 97 ( S.Update ) 47 - 49 2021

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 10 ) 729.e17-729.e25 - 729.e25 2020.12

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Urologic oncology 2020.12

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Urologia internationalis 1 - 8 2020.12

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Numakura K, Kido K, Noro D, Oikawa M, Hosogoe S, Tokui N, Yamamoto H, Narita S, Ito H, Yoneyama T, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1095 - 1100 2020.12

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Anan G, Komatsu K, Hatakeyama S, Iwamura H, Kohada Y, Mikami J, Ito J, Kaiho Y, Shimbo M, Endo F, Yoneyama T, Hashimoto Y, Ohyama C, Hattori K, Sato M

International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1072 - 1077 2020.12

AR amplification of Cell-free DNA predicts poor oncological outcomes in patients with castration resistant prostate cancer

小玉寛健, 畠山真吾, 小西栄, 久保田優花, 相馬理, 松本哲平, 岡本哲平, 米山徹, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会(Web) 108回 851 - 851 2020.12

Urolithiasis and glycosylation (identification of the aberrant glycosylation of osteopontin in urolithiasis)

阿南剛, 阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 佐藤信, 大山力, 大山力

日本泌尿器科学会総会(Web) 108回 283 - 283 2020.12

Boron neutron capture therapy of bladder cancer by tumor vascular endothelium targeting IF7 peptide-boron drug

畠山真吾, 米山徹, 米山美穂子, 山本勇人, 米山高弘, 橋本安弘, 石山新太郎, 鈴木実, 大山力

日本泌尿器科学会総会(Web) 108回 885 - 885 2020.12

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

International journal of clinical oncology 2020.10

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 10 ) 795.e9 - 795.e17 2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama

Clinical genitourinary cancer 18 ( 5 ) e523 - e530 2020.10

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 10 ) 795.e9-795.e17 - 795.e17 2020.10

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 伊藤淳, 海法康裕, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本内分泌学会雑誌 96 ( 2 ) 528 - 528 2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Clinical genitourinary cancer 18 ( 5 ) e523-e530 - e530 2020.10

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 2020.9

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki

International urology and nephrology 2020.9

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Urologic oncology 2020.8

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.8

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings 52 ( 6 ) 1723 - 1728 2020.8

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology 52 ( 8 ) 1421 - 1428 2020.8

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 8 ) 684.e17-684.e24 - 684.e24 2020.8

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.8

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Urologic oncology 2020.7

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Urologic oncology 2020.7

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Urologic oncology 2020.7

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics 39 ( 5 ) 1567 - 1575 2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology 24 ( 7 ) 638 - 645 2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports 3 ( 4 ) 141 - 144 2020.7

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function

Transplantation Proceedings 52 ( 6 ) 1723 - 1728 2020.7

Outcome of ABO Blood Type–Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan

Transplantation Proceedings 52 ( 6 ) 1700 - 1704 2020.7

Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI compass 1 ( 3 ) 100 - 107 2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports 3 ( 4 ) 141 - 144 2020.6

Geriatric 8 screening of frailty in patients with prostate cancer.

International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.6

尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 伊藤淳, 海法康裕, 米山高弘, 橋本安弘, 佐藤信, 大山力

泌尿器科紀要 66 ( 6 ) 180 - 180 2020.6

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Neurourology and urodynamics 39 ( 5 ) 1567 - 1575 2020.5

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology 2020.5

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology 39 ( 3 ) 847 - 853 2020.5

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2020.4

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International journal of urology : official journal of the Japanese Urological Association 27 ( 4 ) 327 - 332 2020.4

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 4 ) 344 - 349 2020.4

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International journal of urology : official journal of the Japanese Urological Association 27 ( 4 ) 327 - 332 2020.4

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Transplantation proceedings 52 ( 6 ) 1700 - 1704 2020.3

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 8 ) 684.e1 - 684.e8 2020.3

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology 2020.3

Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.

Osamu Soma, Shingo Hatakeyama, Tohru Yoneyama, Mitsuru Saito, Hideo Sasaki, Yuki Tobisawa, Daisuke Noro, Yuichiro Suzuki, Masakazu Tanaka, Shin-Ichiro Nishimura, Hiroshi Harada, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

Clinical and experimental nephrology 24 ( 2 ) 174 - 184 2020.2

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.

Masaaki Oikawa, Toshikazu Tanaka, Takuma Narita, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Hirotake Kodama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Pathology oncology research : POR 2020.1

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Hirotake Kodama, Takuya Koie, Masaaki Oikawa, Takuma Narita, Toshikazu Tanaka, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International urology and nephrology 2020.1

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy

米山徹

Pathology & Oncology Research - 2020

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野逸人, 畠山真吾, 濱谷智子, 百田匡毅, 成田拓磨, 小島由太, 岩村大径, 米山徹, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

移植 55 ( Supplement ) 356_1 - 356_1 2020

当科におけるABO不適合移植の移植成績

濱谷智子, 濱野逸人, 畠山真吾, 藤田雄, 村上礼一, 岡本哲平, 鈴木裕一朗, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 齋藤久夫, 鈴木唯司, 大山力

移植 55 ( Supplement ) 360_1 - 360_1 2020

前立腺がんの過剰診断・過剰治療を回避する糖鎖関連バイオマーカー

米山徹, 飛澤悠葵, 畠山真吾, 大山力

泌尿器科 11(1) 99 - 110 2020

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy

古家琢也, 米山徹

International Urology and Nephrology 52 671 - 679 2020

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences 21 ( 1 ) 2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine 16 ( 12 ) 1922 - 1929 2019.12

Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.

Clinical and experimental nephrology 2019.11

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports 9 ( 1 ) 16761 - 16761 2019.11

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Sakae Konishi, Shingo Hatakeyama, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 26 ( 11 ) 1079 - 1081 2019.11

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus 5 ( 6 ) 1120 - 1126 2019.11

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus 5 ( 6 ) 1066 - 1073 2019.11

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology 2019.10

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms 2019.10

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 26 ( 10 ) 992 - 998 2019.10

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Narita S, Kawaguchi T, Habuchi T, Ohyama C

Clinical genitourinary cancer 17 ( 5 ) e1080 - e1089 2019.10

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England) 36 ( 10 ) 88 - 88 2019.9

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Yoshihiko Suda, Robert A Gardiner, Chikara Ohyama

Cancer science 110 ( 8 ) 2573 - 2589 2019.8

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Cancer science 110 ( 8 ) 2573 - 2589 2019.8

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

International journal of urology : official journal of the Japanese Urological Association 26 ( 10 ) 992 - 998 2019.7

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports 2 ( 4 ) 236 - 239 2019.7

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology 23 ( 6 ) 807 - 813 2019.6

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology 23 ( 6 ) 807 - 813 2019.6

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

Clinical genitourinary cancer 17 ( 3 ) e440 - e446 2019.6

Renal cell carcinoma in a lumbar ectopic kidney.

Itsuto Hamano, Shingo Hatakeyama, Osamu Soma, Yusuke Ishibashi, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shoji Nishimura, Takuya Koie, Chikara Ohyama

IJU case reports 2 ( 3 ) 124 - 127 2019.5

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international 123 ( 5 ) 877 - 884 2019.5

尿路結石形成に関与する尿中糖鎖変異オステオポンチン(PolyLac-OPN)のバイオマーカーの可能性

阿南剛, 米山徹, 畠山真吾, 飛澤悠葵, 米山美穂子, 岩村大径, 伊藤淳, 海法康裕, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 鈴木唯司, 佐藤信, 大山力

日本内分泌学会雑誌 95 ( 1 ) 379 - 379 2019.4

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 26 ( 4 ) 522 - 523 2019.4

尿路結石形成に関与する尿中オステオポンチンの糖鎖変異

阿南剛, 米山徹, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 古家琢也, 鈴木唯司, 佐藤信, 大山力

日本尿路結石症学会誌 17 ( 2 ) 117 - 119 2019.3

前立腺がんの過剰診断を克服する診断マーカーの開発

米山徹, 大山力

腎臓内科・泌尿器科 9(4) 349 - 357 2019

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

European urology focus 4 ( 6 ) 946 - 953 2018.12

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology 50 ( 11 ) 1999 - 2005 2018.11

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

BJU international 2018.9

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2018.9

Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

K V Yogesh, Toshiya Kamiyama, Chikara Ohyama, Tohru Yoneyama, Kazuhiro Nouso, Satoshi Kimura, Hiroshi Hinou, Shin-Ichiro Nishimura

MedChemComm 9 ( 8 ) 1351 - 1358 2018.8

Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

Yogesh KV, Kamiyama T, Ohyama C, Yoneyama T, Nouso K, Kimura S, Hinou H, Nishimura SI

MedChemComm 9 ( 8 ) 1351 - 1358 2018.8

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2018.7

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus 2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 9 ( 33 ) 23047 - 23057 2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Oncotarget 9 ( 33 ) 23047 - 23057 2018.5

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

Oncotarget 9 ( 25 ) 17396 - 17405 2018.4

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Oncotarget 9 ( 25 ) 17396 - 17405 2018.4

Impact of bacillus Calmette–Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy

Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

Medical Oncology 35 ( 4 ) 41 2018.4

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

European urology focus 2018.3

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology 2018.2

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma

International Journal of Clinical Oncology 23 ( 4 ) 1 - 8 2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 9 ( 9 ) 8746 - 8755 2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International Journal of Clinical Oncology 23 ( 1 ) 134 - 141 2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Oncotarget 9 ( 9 ) 8746 - 8755 2018.1

Anti-tumor growth effect of STIM1 suppression

Han Chong, Yoneyama Tohru, Toyama Yuichi, Yonekura Manabu, Ohyama Chikara, Murakami Manabu

Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 ( 0 ) PO4-6-18 2018

Development of high sensitive LacdiNAc-PSA immunoassay system with surface plasmon field- enhanced fluorescence spectroscopy (SPFS)

Kaneko Tomonori, Kaya Takatoshi, Yoneyama Tohru, Tobisawa Yuki, Hatakeyama Shingo, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara, Suda Yoshihiko

Japan Journal of Molecular Tumor Marker Research 33 ( 0 ) 19 - 20 2018

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences 18 ( 12 ) 2017.12

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

International journal of molecular sciences 18 ( 12 ) 2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology 22 ( 6 ) 1087 - 1093 2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 22 ( 6 ) 1087 - 1093 2017.12

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 60 ) 101500 - 101508 2017.11

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese Journal of Clinical Oncology 48 ( 2 ) 184 - 189 2017.11

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology 47 ( 11 ) 1078 - 1082 2017.11

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 8 ( 49 ) 86130 - 86142 2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 8 ( 47 ) 83183 - 83194 2017.10

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study

ONCOTARGET 8 ( 49 ) 86130 - 86142 2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 37 ) 61404 - 61414 2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 39 ) 65492 - 65505 2017.9

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology 17 ( 1 ) 72 - 72 2017.8

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

ONCOTARGET 8 ( 47 ) 83183 - 83194 2017.8

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 47 ( 11 ) 1078 - 1082 2017.8

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

International journal of molecular sciences 18 ( 8 ) 2017.8

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC UROLOGY 17 ( 1 ) 72 2017.8

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 ( 8 ) 2017.8

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

International journal of clinical oncology 2017.7

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget 8 ( 30 ) 49749 - 49756 2017.7

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer

ONCOTARGET 8 ( 39 ) 65492 - 65505 2017.7

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma

ONCOTARGET 8 ( 30 ) 49749 - 49756 2017.7

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PLOS ONE 12 ( 7 ) e0182136 2017.7

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

ONCOTARGET 8 ( 37 ) 61404 - 61414 2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England) 34 ( 5 ) 90 - 90 2017.5

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

INTERNATIONAL JOURNAL OF UROLOGY 24 ( 5 ) 361 - 366 2017.5

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study

Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama

INTERNATIONAL UROLOGY AND NEPHROLOGY 49 ( 5 ) 811 - 816 2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer

MEDICAL ONCOLOGY 34 ( 5 ) 90 2017.5

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus 2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology 17 ( 1 ) 25 - 25 2017.4

Recent progress and perspectives on prostate cancer biomarkers

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama

International Journal of Clinical Oncology 22 ( 2 ) 214 - 221 2017.4

Clinical relevance of aortic calcification in urolithiasis patients

BMC UROLOGY 17 ( 1 ) 25 2017.4

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 22 ( 2 ) 366 - 372 2017.4

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors

Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

CANCER MEDICINE 6 ( 4 ) 739 - 748 2017.3

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2017.3

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 47 ( 3 ) 252 - 256 2017.3

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated 2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis

Tomokazu Ishikawa, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Tatsuo Kurosawa, Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H. Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 ( 2 ) 2017.2

Effect of heparin bridged transrectal prostate biopsy on the risk of hemorrhage in patients requiring temporary discontinuation of warfarin.

Hamano Itsuto, Hatakeyama Shingo, Yoneyama Tohru, Tobisawa Yuki, Soma Osamu, Matsumoto Teppei

JOURNAL OF CLINICAL ONCOLOGY 35 ( 6 ) 2017.2

Impact of castration resistant status on overall survival for prostate cancer patients treated with radical prostatectomy.

Fujita Naoki, Koie Takuya, Yamamoto Hayato, Imai Atsushi, Tobisawa Yuki, Yoneyama Tohru

JOURNAL OF CLINICAL ONCOLOGY 35 ( 6 ) 2017.2

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: A single-center study.

Hagiwara Kazuhisa, Koie Takuya, Tobisawa Yuki, Yamamoto Hayato, Imai Atsushi, Yoneyama Tohru

JOURNAL OF CLINICAL ONCOLOGY 35 ( 6 ) 2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology 17 ( 1 ) 13 - 13 2017.2

[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].

Ohyama C, Yoneyama T, Tobisawa Y, Ishikawa T, Hatakeyama S, Koie T, Mori K

Rinsho byori. The Japanese journal of clinical pathology 65 ( 2 ) 210 - 217 2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy

BMC UROLOGY 17 ( 1 ) 13 2017.2

[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].

Ohyama C, Yoneyama T, Tobisawa Y, Ishikawa T, Hatakeyama S, Koie T, Mori K

Rinsho byori. The Japanese journal of clinical pathology 65 ( 2 ) 210 - 217 2017.2

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer

Kazuhisa Hagiwara, Yuki Tobisawa, Takatoshi Kaya, Tomonori Kaneko, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Yoshihiko Suda, Chikara Ohyama, Tohru Yoneyama

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 ( 2 ) 2017.2

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

PloS one 12 ( 7 ) e0182136 - e0182136 2017

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study

Oncotarget 8 ( 60 ) 101500 - 101508 2017

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology 2016.12

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

International journal of clinical oncology 2016.12

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus 5 ( 1 ) 1917 2016.12

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma

Masaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, Yuki Tobisawa, Takuma Narita, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Shintaro Narita, Atsushi Sasaki, Norihiko Tsuchiya, Tomonori Habuchi, Ippei Takahashi, Shigeyuki Nakaji and Chikara Ohyama

European Urology Focus 2016.11

Recent progress and perspectives on prostate cancer biomarkers.

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama

International journal of clinical oncology 2016.10

[Development of promising biomarkers for prostate cancer].

Tohru Yoneyama, Chikara Ohyama

Nihon rinsho. Japanese journal of clinical medicine 74 Suppl 3 191 - 195 2016.5

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

INTERNATIONAL JOURNAL OF UROLOGY 23 ( 5 ) 412 - 417 2016.5

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery

Tendo Sato, Shingo Hatakeyama, Teppei Okamoto, Hayato Yamamoto, Shogo Hosogoe, Yuki Tobisawa, Tohru Yoneyama, Eiji Hashiba, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuyoshi Hirota, Chikara Ohyama

PLOS ONE 11 ( 5 ) e0153961 2016.5

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International Journal of Clinical Oncology 21 ( 2 ) 379 - 383 2016.4

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Mikami J, Tobisawa Y, Yoneyama T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M

Cancer science 107 ( 3 ) 359 - 368 2016.2

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2016.2

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer

Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

PLOS ONE 11 ( 2 ) e0149544 2016.2

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Biochemical and biophysical research communications 470 ( 1 ) 150 - 156 2016.1

Core 2 (beta-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 470 ( 1 ) 150 - 156 2016.1

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus 5 ( 1 ) 1917 - 1917 2016

The potential role of blood group antigen-targeting peptide in ABO-incompatible in renal transplantation

69 ( 13 ) 1093 - 1100 2015.12

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer science 2015.12

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis

Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 5 ) 1018 - 1025 2015.10

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PloS one 10 ( 9 ) e0138520 - e0138520 2015.9

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

International urology and nephrology 47 ( 9 ) 1509 - 1514 2015.9

Detection of Core2 beta-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PLOS ONE 10 ( 9 ) e0138520 2015.9

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

INTERNATIONAL UROLOGY AND NEPHROLOGY 47 ( 9 ) 1509 - 1514 2015.9

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International journal of clinical oncology 2015.7

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 2 ) 369 - 374 2015.4

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC Urology 15 32 2015.4

International journal of clinical oncology 2015.2

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 20 ( 1 ) 176 - 181 2015.2

Quantification of Prostate Cancer-Associated Aberrant Glycosylation of Prostate-Specific Antigen

Chikara Ohyama, Takuya Koie, Tohru Yoneyama, Yuki Tobisawa

Glycoscience: Biology and Medicine 1373 - 1377 2015.1

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England) 32 ( 1 ) 421 - 421 2015.1

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

MEDICAL ONCOLOGY 32 ( 1 ) 421 2015.1

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC urology 15 ( 1 ) 32 - 32 2015

SerumTri- and Tetra-Antennary N-Glycan is a Potential Predictive Biomarker for Castration-Resistant Prostate Cancer

Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama

PROSTATE 74 ( 15 ) 1521 - 1529 2014.11

Testicular metastasis of prostate cancer: a case report.

Ayumu Kusaka, Takuya Koie, Hayato Yamamoto, Itsuto Hamano, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Case reports in oncology 7 ( 3 ) 643 - 647 2014.9

Testicular metastasis of prostate cancer: a case report.

Ayumu Kusaka, Takuya Koie, Hayato Yamamoto, Itsuto Hamano, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Case reports in oncology 7 ( 3 ) 643 - 7 2014.9

Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.

Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama

The Prostate 74 ( 15 ) 1521 - 1529 2014.8

Tubulocystic renal cell carcinoma in the left kidney: a case report.

Yusuke Ishibashi, Takuya Koie, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Journal of medical case reports 8 265 - 265 2014.7

Tubulocystic renal cell carcinoma in the left kidney: A case report

Yusuke Ishibashi, Takuya Koie, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Journal of Medical Case Reports 8 ( 1 ) 265 2014.7

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.

Tohru Yoneyama, Chikara Ohyama, Shingo Hatakeyama, Shintaro Narita, Tomonori Habuchi, Takuya Koie, Kazuyuki Mori, Kazuya I P J Hidari, Maho Yamaguchi, Takashi Suzuki, Yuki Tobisawa

Biochemical and biophysical research communications 448 ( 4 ) 390 - 396 2014.6

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer

Tohru Yoneyama, Chikara Ohyama, Shingo Hatakeyama, Shintaro Narita, Tomonori Habuchi, Takuya Koie, Kazuyuki Mori, Kazuya I. P. J. Hidari, Maho Yamaguchi, Takashi Suzuki, Yuki Tobisawa

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 448 ( 4 ) 390 - 396 2014.6

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology 2014.5

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England) 31 ( 5 ) 949 - 949 2014.5

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

MEDICAL ONCOLOGY 31 ( 5 ) 949 2014.5

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.

International journal of clinical oncology 2014.4

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

World journal of surgical oncology 12 134 - 134 2014.4

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

WORLD JOURNAL OF SURGICAL ONCOLOGY 12 134 2014.4

Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Norihiko Tsuchiya, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama

The Journal of urology 191 ( 3 ) 805 - 813 2014.3

Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.

S Hatakeyama, T Fujita, R Murakami, Y Suzuki, N Sugiyama, H Yamamoto, A Okamoto, A Imai, Y Tobisawa, T Yoneyama, K Mori, T Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings 46 ( 2 ) 445 - 448 2014.3

Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.

T Sato, Takahiro Yoneyama, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, H Yamamoto, A Okamoto, A Imai, S Hatakeyama, Y Hashimoto, T Koie, C Ohyama

Transplantation proceedings 46 ( 2 ) 634 - 636 2014.3

BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.

M Oikawa, S Hatakeyama, T Fujita, R Murakami, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings 46 ( 2 ) 616 - 619 2014.3

BK Virus-Associated Urothelial Carcinoma of a Ureter Graft in a Renal Transplant Recipient: A Case Report

M. Oikawa, S. Hatakeyama, T. Fujita, R. Murakami, K. Hagiwara, T. Narita, D. Noro, T. Tanaka, Y. Tanaka, Y. Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y. Hashimoto, T. Koie, S. Narumi, C. Ohyama

TRANSPLANTATION PROCEEDINGS 46 ( 2 ) 616 - 619 2014.3

Serum N-Glycan Alteration Associated with Renal Cell Carcinoma Detected by High Throughput Glycan Analysis

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Norihiko Tsuchiya, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama

JOURNAL OF UROLOGY 191 ( 3 ) 805 - 813 2014.3

Renal Cell Carcinoma Detected by Preoperative Kidney Transplant Donor Examination: A Case Report

T. Sato, Takahiro Yoneyama, K. Hagiwara, T. Narita, D. Noro, T. Tanaka, Y. Tanaka, Y. Tobisawa, Tohru Yoneyama, H. Yamamoto, A. Okamoto, A. Imai, S. Hatakeyama, Y. Hashimoto, T. Koie, C. Ohyama

TRANSPLANTATION PROCEEDINGS 46 ( 2 ) 634 - 636 2014.3

Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Megumi Tsushima, Kazuko Hirose, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Shin-Ichiro Nishimura, Chikara Ohyama

TheScientificWorldJournal 2013 268407 - 268407 2013.12

Random Phage Display-Based Screening of Peptides that Bind to Botulinum Neurotoxin Binding Protein, Nontoxic Nonhemagglutinin.

Sagane Y, Miyata K, Kurihara S, Yoneyama T, Inui K, Miyashita SI, Hayashi S, Suzuki T, Niwa K, Watanabe T.

Current Microbiology 67 ( 2 ) 188 - 192 2013.8

Random Phage Display-Based Screening of Peptides that Bind to Botulinum Neurotoxin Binding Protein, Nontoxic Nonhemagglutinin

Yoshimasa Sagane, Keita Miyata, Sayuri Kurihara, Tohru Yoneyama, Ken Inui, Shin-Ichiro Miyashita, Shintaro Hayashi, Tomonori Suzuki, Koichi Niwa, Toshihiro Watanabe

CURRENT MICROBIOLOGY 67 ( 2 ) 188 - 192 2013.8

BLOOD GROUP ANTIGEN-TARGETING PEPTIDE SUPPRESSES ANTI-BLOOD GROUP ANTIBODY BINDING TO ANTIGEN IN RENAL GLOMERULAR CAPILLARIES AFTER ABO-INCOMPATIBLE BLOOD REPERFUSION

Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Naoki Sugiyama, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Michiko N. Fukuda, Chikara Ohyama

JOURNAL OF UROLOGY 189 ( 4 ) E864 - E864 2013.4

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion

Yoneyama Tohru, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda NM, Ohyama C

Transplantation 95 ( 3 ) 2013.2

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis

SCIENTIFIC WORLD JOURNAL 2013 1 - 10 2013

Fer kinase regulates cell migration through α-dystroglycan glycosylation (共著)

Yoneyama T, Angata K, Bao X, Courtneidge S, Chanda S, & Fukuda M.

Molecular Biology of the cell 23 ( 5 ) 771 - 780 2012.6

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population

HASHIMOTO Yasuhiro, OKAMOTO Akiko, IMAI Atsushi, YONEYAMA Tohru, HATAKEYAMA Shingo, YONEYAMA Takahiro, KOIE Takuya, KAMINURA Noritaka, OHYAMA Chikara

17 ( 2 ) 119 - 123 2012.4

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population

Yasuhiro Hashimoto, Akiko Okamoto, Atsushi Imai, Tohru Yoneyama, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Noritaka Kaminura, Chikara Ohyama

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 17 ( 2 ) 119 - 123 2012.4

Fer kinase regulates cell migration through alpha-dystroglycan glycosylation

Tohru Yoneyama, Kiyohiko Angata, Xingfeng Bao, Sara Courtneidge, Sumit K. Chanda, Minoru Fukuda

MOLECULAR BIOLOGY OF THE CELL 23 ( 5 ) 771 - 780 2012.3

A Switch From Conventional Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Kidney Transplant Recipients

S. Hatakeyama, T. Fujita, T. Yoneyama, T. Yoneyama, T. Koie, Y. Hashimoto, H. Saitoh, T. Funyu, S. Narumi, C. Ohyama

TRANSPLANTATION PROCEEDINGS 44 ( 1 ) 121 - 123 2012.1

Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain

Matsuo T, Miyata K, Inui K, Ito H, Horiuchi R, Suzuki T, Yoneyama T, Oguma K, Niwa K, Watanabe T & Ohyama T

FEMS Immunology and Medical Microbiology 63 ( 1 ) 35 - 43 2011.10

Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi

Tomohito Matsuo, Keita Miyata, Ken Inui, Hiroaki Ito, Ryohta Horiuchi, Tomonori Suzuki, Tohru Yoneyama, Keiji Oguma, Koichi Niwa, Toshihiro Watanabe, Tohru Ohyama

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 63 ( 1 ) 35 - 43 2011.10

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Hashimoto Y, Okamoto A, Imai A, Yoneyama T, Hatakeyama S, Yoneyama T, Koie T, Kaminura N & Ohyama C

International Journal of Clinical Oncology 17 ( 2 ) 119 - 123 2011.4

APP-013 腎細胞癌における血清N-結合型糖鎖の網羅的解析による新規バイオマーカーの検索(総会賞応募ポスター,第99回日本泌尿器科学会総会)

畠山真吾, 山本隼人, 米山徹, 盛和行, 工藤茂将, 米山高弘, 古家琢也, 神村典孝, 對馬惠, 舟生富壽, 天野麻穂, 西村紳一郎, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 299 2011

PP-390 ABO血液型抗原をマスクするペプチド配列のスクリーニング(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

米山徹, 畠山真吾, 今西賢吾, 得居範子, 岡本哲平, 杉山尚樹, 鈴木裕一朗, 工藤茂将, 米山高弘, 盛和行, 古家琢也, 神村典孝, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 468 2011

PP-038 ナノパーティクルBCGはBCG生菌無効の細胞株に対して直接効果を有する(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

盛和行, 米山徹, 今西賢悟, 得居範子, 杉山尚樹, 立和田得志, 畠山真吾, 工藤茂将, 米山高弘, 古家琢也, 神村典孝, 中川昌之, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 409 2011

OP-186 CRPCに対するDocetaxel,Prednisolone,Zoledronic acid療法の検討(前立腺腫瘍/薬物療法2,一般演題口演,第99回日本泌尿器科学会総会)

米山高弘, 岡本哲平, 得居範子, 鈴木裕一朗, 杉山尚樹, 米山徹, 畠山真吾, 工藤茂将, 盛和行, 古家琢也, 神村典孝, 羽渕友則, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 371 2011

OP-156 限局性前立腺癌のブラキ治療後排尿障害に対するα1ブロッカーの効果について(前立腺腫瘍/放射線治療1,一般演題口演,第99回日本泌尿器科学会総会)

神村典孝, 岡本哲平, 得居範子, 杉山尚樹, 鈴木裕一朗, 畠山真吾, 工藤茂将, 米山高弘, 古家琢也, 米山徹, 盛和行, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 366 2011

Identification of carbohydrate-binding proteins by carbohydrate mimicry peptides

Fukuda N M, Yoneyama T

Methods in Enzymology 478 563 - 572 2010.9

Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells

Niwa K, Yoneyama T, Ito H, Taira M, Chikai T, Kouguchi H, Suzuki T, Hasegawa K, Miyata, K, Inui, K, Ikeda T, Watanabe T, and Ohyama T

Veterinary Microbiology 141 ( 3-4 ) 312 - 320 2010.3

Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells

Koichi Niwa, Tohru Yoneyama, Hiroaki Ito, Maya Taira, Tomoyuki Chikai, Hirokazu Kouguchi, Tomonori Suzuki, Kimiko Hasegawa, Keita Miyata, Ken Inui, Toshihiko Ikeda, Toshihiro Watanabe, Tohru Ohyama

VETERINARY MICROBIOLOGY 141 ( 3-4 ) 312 - 320 2010.3

IDENTIFICATION OF CARBOHYDRATE-BINDING PROTEINS BY CARBOHYDRATE MIMICRY PEPTIDES

Michiko N. Fukuda, Tohru Yoneyama

METHODS IN ENZYMOLOGY, VOL 478: GLYCOMICS 478 563 - 572 2010

Expression and stability of the nontoxic component of the botulinum toxin complex

Miyata K, Yoneyama T, Suzuki T, Kouguchi H, Inui K, Niwa K, Watanabe T and Ohyama T

Biochemical and Biophysical Research Communications 384 ( 1 ) 126 - 130 2009.6

Expression and stability of the nontoxic component of the botulinum toxin complex

Keita Miyata, Tohru Yoneyama, Tomonori Suzuki, Hirokazu Kouguchi, Ken Inui, Koichi Niwa, Toshihiro Watanabe, Tohru Ohyama

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 384 ( 1 ) 126 - 130 2009.6

Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex

Suzuki T, Yoneyama T, Miyata K, Mikami A, Chikai T, Inui K, Kouguchi H, Niwa K, Watanabe T, Miyazaki S and Ohyama T

Biochemical and Biophysical Research Communications 379 ( 2 ) 309 - 313 2009.2

Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex

Tomonori Suzuki, Tohru Yoneyama, Keita Miyata, Akifumi Mikami, Tomoyuki Chikai, Ken Inui, Hirokazu Kouguchi, Koichi Niwa, Toshihiro Watanabe, Satoru Miyazaki, Tohru Ohyama

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 379 ( 2 ) 309 - 313 2009.2

Clostridium botulinum Serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid

Yoneyama T, Miyata, K, Chikai, T, Mikami, A, Suzuki, T, Hasegawa, K, Ikeda, T, Watanabe, T, Ohyama, T and Niwa, K

FEMS Immunology & Medical Microbiology 54 ( 3 ) 290 - 298 2008.12

Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid（ボツリヌスD型神経毒素と毒素複合体のシアル酸を介したウシ血管内皮細胞への結合）

Yoneyama T, Miyata K, Chikai T, Mikami A, Suzuki T, Hasegawa K, Ikeda T, Watanabe T, Ohyama T, Niwa K

FEMS Immunology and Medical Microbiology 54 299 - 313 2008.12

Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid

Tohru Yoneyama, Keita Miyata, Tomoyuki Chikai, Akifumi Mikami, Tomonori Suzuki, Kimiko Hasegawa, Toshihiko Ikeda, Toshihiro Watanabe, Tohru Ohyama, Koichi Niwa

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 54 ( 3 ) 290 - 298 2008.12

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms

Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, Sato Y, Kouguchi H, Yoneyama T, Niwa K, Ikeda T, and Ohyama T

THE JOURNAL OF BIOLOGICAL CHEMISTRY 282 ( 34 ) 24777 - 24783 2007.8

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms

Kimiko Hasegawa, Toshihiro Watanabe, Tomonori Suzuki, Akihito Yamano, Tetsuo Oikawa, Yasuhiko Sato, Hirokazu Kouguchi, Tohru Yoneyama, Koichi Niwa, Toshihiko Ikeda, Tohru Ohyama

JOURNAL OF BIOLOGICAL CHEMISTRY 282 ( 34 ) 24777 - 24783 2007.8

Expression and characterization of a recombinant unique acid phosphatase from kidney bean hypocotyl exhibiting chloroperoxidase activity in the yeast Pichia pastoris

Yoneyama T, Taira M, Suzuki T, Nakamura M, Niwa K, Watanabe T, and Ohyama T

Protein Expression and Purification 53 ( 1 ) 31 - 39 2007.5

Expression and characterization of a recombinant unique acid phosphatase from kidney bean hypocotyl exhibiting chloroperoxidase activity in the yeast pichia pastoris

Tohru Yoneyama, Maya Taira, Tomonori Suzuki, Masao Nakamura, Koichi Niwa, Toshihiro Watanabe, Tohru Ohyama

PROTEIN EXPRESSION AND PURIFICATION 53 ( 1 ) 31 - 39 2007.5

Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Suzuki T, Kouguchi H, Watanabe T, Hasegawa K, Yoneyama T, Niwa K, Nishikawa A, Lee J-C, and Ohyama T

The Protein Journal 26 ( 3 ) 173 - 181 2007.4

Effect of nicking the c-terminal region of the Clostridium botulinum serotype d neurotoxin heavy chain on its toxicity and molecular properties

Tomonori Suzuki, Hirokazu Kouguchi, Toshihiro Watanabe, Kimiko Hasegawa, Tohru Yoneyama, Koichi Niwa, Atsushi Nishikawa, Jae-Chul Lee, Keiji Oguma, Tohru Ohyama

PROTEIN JOURNAL 26 ( 3 ) 173 - 181 2007.4

Study on kidney bean hypocotyls specific acid phosphatase exhiubiting vanadate-dependent chloroperoxidase activity

Yoneyama T, Shiozawa M, Nakamura M, Suzuki T, Sagane Y, Katoh Y, Watanabe T, Ohyama T.

J Biol Chem. 279 ( 36 ) 37477 - 37488 2007.3

Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947

Kouguchi, H, Suzuki, T, Hasegawa, K, Mutoh, S, Watanabe, T, Niwa, K, Yoneyama T, Katoh Y, and Ohyama T

Journal of Microbiological Methods 67 ( 3 ) 416 - 423 2006.12

Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947

Hirokazu Kouguchi, Tomonori Suzuki, Kimiko Hasegawa, Shingo Mutoh, Toshihiro Watanabe, Koichi Niwa, Tohru Yoneyama, Yoshinobu Katoh, Tohru Ohyama

JOURNAL OF MICROBIOLOGICAL METHODS 67 ( 3 ) 416 - 423 2006.12

Characterization of a novel acid phosphatase from embryonic axes of kidney bean exhibiting vanadate-dependent chloroperoxidase activity

Yoneyama T, Shiozawa M, Nakamura M, Suzuki T, Sagane Y, Katoh Y, Watanabe T, and Ohyama T

THE JOURNAL OF BIOLOGICAL CHEMISTRY 279 ( 36 ) 37477 - 37484 2004.9

Characterization of a novel acid phosphatase from embryonic axes of kidney bean exhibiting vanadate-dependent chloroperoxidase activity

T Yoneyama, M Shiozawa, M Nakamura, T Suzuki, Y Sagane, Y Katoh, T Watanabe, T Ohyama

JOURNAL OF BIOLOGICAL CHEMISTRY 279 ( 36 ) 37477 - 37484 2004.9

　PREV-NEXT　

<YONEYAMA Tohru>

Papers - YONEYAMA Tohru